BioLineRx Ltd (BLRX): A PDUFA delay would have driven the st...

Reply Private New

Next 10 Prev Next

Send PM Follow Ignore

Followers	144
Posts	27608
Boards Moderated	3
Alias Born	02/07/2004

midastouch017

Re: murocman post# 2648

Thursday, 09/14/2023 1:40:44 AM

Thursday, September 14, 2023 1:40:44 AM

A PDUFA delay would have driven
the stock to 50 cents.
What is causing the downfall is this:

BioLineRx Announces $15 Million Registered Direct Offering
September 19, 2022

TEL AVIV, Israel, Sept. 19, 2022 /PRNewswire/ -- BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a pre-commercial-stage biopharmaceutical company focused on oncology, today announced that it has entered into definitive agreements with several institutional investors for the issuance and sale in a registered direct offering of 13,636,365 of the Company's American Depositary Shares (ADSs) and warrants to purchase up to an aggregate of 13,636,365 ADSs, at a combined purchase price of $1.10 per ADS and associated warrant. Each ADS represents fifteen (15) ordinary shares, par value NIS 0.10 per share, of BioLineRx. The offering is expected to close on or about September 21, 2022, subject to satisfaction of customary closing conditions.

The warrants will have an exercise price of $1.15 per ADS and will be exercisable at any time upon issuance and will expire five years from the date of issuance.